The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Arbutus Biopharma Corporation (NASDAQ:ABUS) is one of the best biotech penny stocks to buy in 2026. On March 23, Arbutus Biopharma concluded 2025 in a robust financial position, reporting $91.5 ...
The good news for Arbutus Biopharma today is that a court of appeals is backing up the U.S. Patent and Trademark Office in supporting the company’s LNP patents. LNP’s are used in RNA-based vaccines to ...
Arbutus Biopharma targets chronic hepatitis B with Imdusiran, addressing a vast, unmet medical need. Read more on ABUS stock ...
Chardan Capital analyst Keay Nakae maintained a Buy rating on Arbutus Biopharma (ABUS – Research Report) yesterday. The company’s shares closed yesterday at $2.55. According to TipRanks, Nakae is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results